ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME
生物活性體外研究 用途與合成方法 MSDS ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME價(jià)格(試劑級(jí)) 上下游產(chǎn)品信息
| 中文名稱 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME |
|---|---|
| 中文同義詞 | N-(1-AMINO-4-METHYLSULFANYL-1-OXOBUTAN-2-YL)-2-[[2-[[2-[(2-AMINO-3-PHENYLPROPANOYL)AMINO]-3-PHENYLPROPANOYL]AMINO]ACETYL]AMINO]-4-METHYLPENTANAMIDE;神經(jīng)肽P物質(zhì)7-11;Α-雷鎖辛甲酸;P物質(zhì)肽SUBSTANCE P(7-11);化合物SUBSTANCE P 7-11(TFA) |
| 英文名稱 | SUBSTANCE P (7-11) |
| 英文同義詞 | SUBSTANCE P (7-11);SUBSTANCE P FRAGMENT 7-11;PHE-PHE-GLY-LEU-MET-NH2;PENTA-SUBSTANCE P;FFGLM-NH2;H-PHE-PHE-GLY-LEU-MET-NH2;SUBSTANCE P FRAGMENT 7-11 ACETATE);L-Phe-L-Phe-Gly-L-Leu-L-Met-NH2 |
| CAS號(hào) | 51165-05-0 |
| 分子式 | C31H44N6O5S |
| 分子量 | 612.78 |
| EINECS號(hào) | |
| 相關(guān)類別 | 多肽;對(duì)照品;標(biāo)準(zhǔn)品;Peptide |
| Mol文件 | 51165-05-0.mol |
| 結(jié)構(gòu)式 |  |
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME 性質(zhì)
| 沸點(diǎn) | 1003.3±65.0 °C(Predicted) |
|---|---|
| 密度 | 1?+-.0.06 g/cm3(Predicted) |
| 儲(chǔ)存條件 | -15°C |
| 溶解度 | 溶于二甲基亞砜 |
| 酸度系數(shù)(pKa) | 13.26±0.46(Predicted) |
| 形態(tài) | 固體 |
| 顏色 | 白色至米白色 |
Substance P (7-11) 是神經(jīng)肽物質(zhì)P的C-末端片段，其可引起細(xì)胞內(nèi)鈣濃度的增加。
Substance P (7-11) increases PGE2 and collagenase production at concentrations greater than 1 μM. Substance P (7-11), but not intact SP, SP-(1-4), SP-(1-6), SP- (8-11) or SP-(9-1 1), nor the tachykinins NKA and NKB, causes an increase in the intracellular calcium concentration as measured by the fluorescent dye Fura-2. The maximal change in intracellular calcium induced by 10 μM Substance P (7-11) was 140±30 nM.
安全信息
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2025/02/05 | HY-P1492 | Substance P (7-11) | 51165-05-0 | 2 mg | 500元 |
| 2025/02/05 | HY-P1492 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME Substance P (7-11) | 51165-05-0 | 5mg | 800元 |